36
Participants
Start Date
July 31, 2014
Primary Completion Date
October 31, 2014
Study Completion Date
October 31, 2014
Telmisartan/Amlodipine
Telmisartan/Amlodipine fixed-dose combination
Telmisartan/Amlodipine/HCTZ
Telmisartan/Amlodipine/HCTZ fixed-dose combination
Telmisartan/HCTZ
Telmisartan/HCTZ fixed-dose combination
1348.5.001 Boehringer Ingelheim Investigational Site, Kanagawa , Yokohama
Lead Sponsor
Boehringer Ingelheim
INDUSTRY